BROWSE BY STUDY TYPE OR CONFERENCE
All
- All
- MODEL VALIDATION
- CLINICAL VALIDATION
- AACR
- ASCO
- ASH
BROWSE BY YEAR
All
- All
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- Archive
2017">Predicting Mechanisms of Ibrutinib-Resistance in Chronic Lymphocytic Leukemia (CLL) Using Computational-Based Modeling for Personalized Therapy with Clinical Validation
Blood Journal,
2017">Computational Biology Model of ETP-ALL Used to Accurately Classify ETP-ALL Vs Non ETP-ALL Patients with Genomic Input
Blood Journal,
2017">Computational Modeling of Protein Networks Predicts Treatment Outcomes in Multiple Myeloma (MM)
Blood Journal,
2017">Predictive Simulation Modeling of Early T-Cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) Patient Genomics Identifies Targeted Combination Treatment Options
Blood Journal,
2017">Personalized Therapy Design for Early T-Cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) Using Computational Biology Modeling with in Vitro Validation
Blood Journal,
2017">The Oral Proteasome Inhibitor Ixazomib, Alone and in Combination with Ibrutinib, Induces Lethality in Waldenstrom Macroglobulinemia Cells That Are Resistant to Ibrutinib